Mediq may combine its various medical imaging companies into onebusiness unit, according to Michael Sandler, senior vice presidentand CFO. The consolidation would be part of a general restructuringand downsizing of the diversified health-care company
Mediq may combine its various medical imaging companies into onebusiness unit, according to Michael Sandler, senior vice presidentand CFO. The consolidation would be part of a general restructuringand downsizing of the diversified health-care company (SCAN 1/16/91).
Mediq was the largest supplier of mobile computed tomographyand magnetic resonance imaging services until it sold that businessto Mobile Technology (MTI) three years ago (SCAN 4/13/88). Thefirm continues to offer mobile ultrasound, nuclear medicine andx-ray services, however.
If a consolidation of medical imaging businesses takes place,the mobile operations would be combined with Mediq Equipment andMaintenance Services (MEMS), a Dallas-based independent serviceorganization for imaging equipment, and Mediq Diagnostic and TreatmentCenters (MDTC). MDTC, based at corporate headquarters in Pennsauken,NJ, runs six imaging centers.
The medical imaging companies are a core part of Mediq's businessstrategy and will not be divested in the restructuring program,Sandler said. The same cannot be said for Mediq's Copelco FinancialServices, a medical equipment lessor. The mix of financial servicesand Mediq's health-care businesses has confused investors, henoted.
Following recommendations by Smith Barney last year, Mediqplans to divest many of its 24 business units. The divestitureswill help raise cash to pay off a large debt load and focus thecompany on business areas that are less confusing to bankers,customers, employees and stockholders, Sandler said.
"We are overleveraged and the stock market doesn't understandus," he said.
Combining medical imaging businesses will help reduce corporateoverhead and make use of complementary expertise. Mediq expectsthe combination will be appealing to the financial markets. Ifthe reaction is favorable, Mediq might consider spinning the unitoff into a separate company, Sandler said.
Mediq has already taken what could be considered a first stepin the consolidation of its imaging businesses. The parent companyappointed J. Thomas Owings, president of MDTC, as president ofMEMS last month (see following story).
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.